Problems and Barriers in Providing Medical Cannabis Services for Palliative Care Patients: Perspectives of Healthcare Professionals in Pattani Province

Main Article Content

Wirakarn Chuaywong
Korngamon Rookkapan

Abstract

Objectives: To examine the service delivery process, problems and barriers within medical cannabis service system for palliative care patients in Mueang District, Pattani Province, and to propose approaches for improving the service. Methods: The researchers in-depth interviewed 15 personnel involved in medical cannabis services and palliative care in Mueang District, Pattani Province and observed service delivery. The researchers also conducted a focus group discussion among 8 administrators and practitioners to propose system improvement approaches. Data were collected from March to September 2024 and analyzed using thematic analysis. Results: The medical cannabis clinic operates as a multidisciplinary service system, bridging hospitals and sub-district health promoting hospitals (SHPHs). The services encompass screening, diagnosis, prescribing, counseling, and follow-up, with information shared with the community to ensure patients receive appropriate and continuous care. Problems in the medical cannabis service system were categorized into 7 aspects: 1) personnel: limitations in knowledge, experience, confidence, and insufficient workforce 2) medication: short shelf life of medical cannabis, difficulty in using drop formulations, and discontinuation of drug supply 3) treatment guidelines: medical cannabis is not considered a first-line treatment, and practice guidelines conflict with policies aimed at increasing access 4) physical facility and environment: The current setup is not conducive to service delivery. 5) service system: lack of coordination among personnel and between hospitals and SHPHs 6) public relations: limited publicity and lack of local-language media and 7) patients receiving service: declining numbers, limited health literacy regarding cannabis, behaviors causing discomfort to healthcare staff, refusal of cannabis medications, and cannabis use conflicting with patients' personal beliefs. Approaches for improving medical cannabis services comprise fostering literacy and confidence among healthcare personnel, improving workflows and inter-organizational integration, upgrading service facilities, strengthening medication management systems, increasing public awareness, promoting cannabis literacy among the public, and conducting further research on medical cannabis use. Conclusion: Seven key problem areas were identified in medical cannabis services. Improvement should focus on enhancing the knowledge and confidence among healthcare personnel, ensuring readiness in terms of workforce, medications, and service facilities, improving service processes, increasing public awareness, and promoting cannabis literacy and public trust to support the appropriate and safe use of medical cannabis.

Article Details

Section
Research Articles

References

Thaenkham T, Kessomboon P, Chumworathayi B, Dabpookhiew P, Pittayakittiwong P, Srivong T, et al. Quality of life and effects of cannabis use in cancer patients receiving palliative care. Journal of Nursing Science and Health. 2025; 48: 62-76.

Buamahakul R, Buamahakul T. Treatment effects and adverse drug reaction of Metta-Osot cannabis oil from medical records in end stage cancer patients received treatment at a cannabis clinic, Thai traditional and integrated medicine hospital, Bangkok. Journal of Public Health and Development 2024; 38: 1-11.

Singjai S. Effect of using medical cannabis clinic services in palliative care patients at MaeOn hospital, MaeOn district, Chiang Mai province. Journal of Nakornping Hospital. 2024; 15: 321-35.

Thanasitthichai S, Simasatikul C, Srisubat A, Krongkaew W, Kunin B, Seedadard R, et al. Safety and efficacy evaluation of the 1st legalized pharmaceutical grade medical cannabis for palliative cancer in Thailand. Journal of the Department of Medical Services. 2020; 45: 116-22.

Lucas P, Boyd S, Milloy MJ, Walsh Z. Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: results of a large prospective study. Pain Med. 2021; 22: 727-39.

Department of Medical Services, Ministry of Public Health. Guidelines for providing integrated medical cannabis clinic services. Bangkok: WVO Office of Printing Mill; 2021.

Rattanachun V, Wongphuka K, Wongsampant N. Service management of medical cannabis clinics and cannabis product prescription at government hospitals in Nan province. Journal of Thai Traditional and Alternative Medicine. 2023; 21: 433-48.

Noksakda C, Peeratanarath W, Surawan J. Development of integrative cannabis clinic for medicine in Phon hospital, Khon Kaen. Journal of Health Science of Thailand. 2024; 33: 289-302.

Khaimuk P. Lesson in the development of the health service system (service plan) cannabis branch Kanchanaburi province. Academic Journal of Mahasarakham Provincial Public Health Office. 2024; 8: 151-67.

Onmuk P, Sangvichien S, Fakkham S. Study of Thai traditional medical cannabis clinic service model in department of Thai traditional and alternative medicine service, ministry of public health. Journal of Applied Humanities Studies. 2022; 7: 27-39.

Meksawasdichai C. Medical cannabis use in the health region 4 of Thailand. Thai Pharmaceutical and Health Science Journal. 2022; 17: 296-307.

Thuanyota K, Sasuk P, Suksai J. Model development of integrative medical cannabis clinic service in Phon Phisai hospital, Nong Khai. Journal of Health Science and Community Public Health. 2023; 6: 54-65.

Ministry of Public Health. Health data center (HDC) [online]. 2024 [cited Sep 7, 2025]. Available from: hdc.moph.go.th/center/public/standard-subcatalog/2 908 c586a168578a2c4aee3ab13963c9.

Nuchmee A. Medical use of cannabis in Islamic law perspective. Journal of Liberal Arts, Rangsit University. 2021; 15: 77-88.

Miles M, Huberman A. Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage; 1994.

Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981; 19: 127-40.

Department of Medical Services. Guidance on cannabis for medical use. 6th ed. Bangkok: Ministry of Public Health; 2024.

Assanangkornchai S, Saingam D, Thaikla K, Talek M. Views and practices on medical cannabis of unlicensed providers in Thailand: a qualitative study. F1000Res. 2024; 11: 365.

Attonito J, Freeman K, Bone MK, Howard H, Blum C, Luck G. Knowledge, attitudes, and beliefs regarding medical cannabis among patients and providers in Florida's long-term care facilities. Cureus. 2024; 16: e66115.

Karanges EA, Suraev A, Elias N, Manocha R, McGregor IS. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey. BMJ Open. 2018; 8: e022101.

McLennan A, Kerba M, Subnis U, Campbell T, Carlson LE. Health care provider preferences for, and barriers to, cannabis use in cancer care. Curr Oncol. 2020; 27: e199-e205.

Kruger DJ, Mokbel MA, Clauw DJ, Boehnke KF. Assessing health care providers' knowledge of medical cannabis. Cannabis Cannabinoid Res. 2022; 7: 501-7.

Khamjae K, Techakehakij W, Thatayu W, Phetkub N, Subhamani N. Attitudes, and experiences about medical cannabis in palliative care patients and caregivers in Thailand: A qualitative study. Palliat Med Pract. 2025; 19: 15-21.

Withanarachchie V, Rychert M, Wilkins C. Barriers and facilitators to prescribing medicinal cannabis in New Zealand. J Prim Health Care. 2023; 15: 135-46.

Syed S, Singh J, Elkholy H, Rojnic Palavra I, Tomicevic M, Eric A, et al. International perspectives on physician knowledge, attitudes, and practices related to medical cannabis. Front Public Health. 2025; 13: 1463871.

Schlag A, Baldwin D, Barnes M, Bazire S, Coathup R, Curran H, et al. Medical cannabis in the UK: From principle to practice. J Psychopharmacol 2020; 34: 931-7.

Strada L, van Gelder N, Martinelli T, Fraser A, Hipple Walters B. Barriers to accessing prescribed medical cannabis: qualitative insights from people using non-prescribed cannabis for medicinal purposes in the Netherlands. Harm Reduct J. 2025; 23: 13.